23-year trends of antimicrobial resistance in Salmonella Paratyphi A indicates low rates on resistance acquisition
暂无分享,去创建一个
Md. Asadur Rahman | Shahidullah | Y. Hooda | S. Luby | A. M. Tanmoy | S. Saha | N. Islam | Senjuti Saha | D. Garrett | Anik Sarkar | M. Hanif | H. Rahman | D. Das | Munira | M. S. Sajib | M. Alam | M. Amin | 7. SiraJ.
[1] M. Carey. Gateway to Typhoid Conjugate Vaccine Introduction in India and Beyond—Programmatic Effectiveness of a Public Sector Typhoid Conjugate Vaccine Campaign in Navi Mumbai , 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] G. Dougan,et al. Paratype: a genotyping tool for Salmonella Paratyphi A reveals its global genomic diversity , 2022, Nature communications.
[3] J. Andrews,et al. Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India , 2022, medRxiv.
[4] I. Bogoch,et al. Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the Surveillance for Enteric Fever in Asia Project , 2022, The Lancet. Global health.
[5] I. Bogoch,et al. Estimating typhoid incidence from community-based serosurveys: a multicohort study , 2022, The Lancet. Microbe.
[6] G. Kang,et al. Evaluation of Antimicrobial Susceptibility Profile in Salmonella Typhi and Salmonella Paratyphi A: Presenting the Current Scenario in India and Strategy for Future Management , 2021, The Journal of infectious diseases.
[7] S. Saha,et al. Invasive Bacterial Vaccine-Preventable Disease Surveillance: Successes and Lessons Learned in Bangladesh for a Sustainable Path Forward , 2021, The Journal of infectious diseases.
[8] C. Jenkins,et al. Phylogenomics and antimicrobial resistance of Salmonella Typhi and Paratyphi A, B and C in England, 2016–2019 , 2021, Microbial genomics.
[9] K. Neuzil,et al. Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial , 2021, The Lancet.
[10] N. Bar-Zeev,et al. Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study , 2021, The Lancet. Global health.
[11] M. Shoaib,et al. Disc Diffusion Testing of Azithromycin Against Clinical Isolates of Typhoidal Salmonellae: A Diagnostic Conundrum , 2021, Cureus.
[12] C. Parry,et al. Azithromycin susceptibility testing of Salmonella enterica serovar Typhi: Impact on management of enteric fever , 2021, Clinical Infection in Practice.
[13] J. Andrews,et al. Tracking the Emergence of Azithromycin Resistance in Multiple Genotypes of Typhoidal Salmonella , 2021, mBio.
[14] Gemma C. Langridge,et al. Genomic surveillance detects Salmonella enterica serovar Paratyphi A harbouring blaCTX-M-15 from a traveller returning from Bangladesh , 2020, PloS one.
[15] S. Baker,et al. Efficacy of Typhoid Conjugate Vaccine in Nepal: An Interim Analysis of a Participant-and Observer-Blinded Randomized Phase III Trial , 2019, The New England journal of medicine.
[16] Ayenew Molla Lakew,et al. The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The Lancet. Infectious diseases.
[17] J. Andrews,et al. Molecular mechanism of azithromycin resistance among typhoidal Salmonella strains in Bangladesh identified through passive pediatric surveillance , 2019, PLoS neglected tropical diseases.
[18] J. Andrews,et al. Epidemiology of Typhoid and Paratyphoid: Implications for Vaccine Policy , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] S. Baker,et al. Multidrug resistant enteric fever in South Asia: unmet medical needs and opportunities , 2019, British Medical Journal.
[20] I. Bogoch,et al. Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance. , 2019, The Lancet. Infectious diseases.
[21] R. Adhikary,et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002-2013. , 2019, Medical journal, Armed Forces India.
[22] Tetsuya Matsumoto,et al. Characteristics of Resistance Mechanisms and Molecular Epidemiology of Fluoroquinolone-Nonsusceptible Salmonella enterica Serovar Typhi and Paratyphi A Isolates from a Tertiary Hospital in Dhaka, Bangladesh. , 2018, Microbial drug resistance.
[23] S. Saha,et al. Designing Comprehensive Public Health Surveillance for Enteric Fever in Endemic Countries: Importance of Including Different Healthcare Facilities , 2018, The Journal of infectious diseases.
[24] T. Burki. Typhoid conjugate vaccine gets WHO prequalification. , 2018, The Lancet. Infectious diseases.
[25] David R Murdoch,et al. Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: Antimicrobial resistance and implications for vaccine policy , 2018, bioRxiv.
[26] Priyanka Sharma,et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade , 2018, Indian journal of medical microbiology.
[27] S. Baker,et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella Paratyphi isolated in a tertiary Kathmandu hospital , 2017, PLoS neglected tropical diseases.
[28] R. Black,et al. Integration of enteric fever surveillance into the WHO-coordinated Invasive Bacterial-Vaccine Preventable Diseases (IB-VPD) platform: A low cost approach to track an increasingly important disease , 2017, PLoS neglected tropical diseases.
[29] P. Khanal,et al. Renaissance of Conventional First-Line Antibiotics in Salmonella enterica Clinical Isolates: Assessment of MICs for Therapeutic Antimicrobials in Enteric Fever Cases from Nepal , 2017, BioMed research international.
[30] D. Ahmed,et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005–2014 , 2017, Antimicrobial Resistance & Infection Control.
[31] F. Weill,et al. Genomic analysis of Salmonella enterica serotype Paratyphi A during an outbreak in Cambodia, 2013–2015 , 2016, Microbial genomics.
[32] V. Mogasale,et al. What proportion of Salmonella Typhi cases are detected by blood culture? A systematic literature review , 2016, Annals of Clinical Microbiology and Antimicrobials.
[33] S. Dutta,et al. Antimicrobial Resistance, Virulence Profiles and Molecular Subtypes of Salmonella enterica Serovars Typhi and Paratyphi A Blood Isolates from Kolkata, India during 2009-2013 , 2014, PloS one.
[34] M. Forouzanfar,et al. Estimating the Burden of Paratyphoid A in Asia and Africa , 2014, PLoS neglected tropical diseases.
[35] A. Zaidi,et al. A three year review of antimicrobial resistance of Salmonella enterica serovars Typhi and Paratyphi A in Pakistan , 2014 .
[36] R. Black,et al. Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010 , 2012, Journal of global health.
[37] J. Clemens,et al. Trends and disease burden of enteric fever in Guangxi province, China, 1994-2004. , 2010, Bulletin of the World Health Organization.
[38] J. Crump,et al. Global trends in typhoid and paratyphoid Fever. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[39] J. Wain,et al. Salmonella Paratyphi A Rates, Asia , 2005, Emerging infectious diseases.
[40] A. Pandey,et al. Drug-resistant Salmonella enterica serotype paratyphi A in India. , 2000, Emerging infectious diseases.
[41] Meeting of the Strategic Advisory Group of Experts on Immunization, November 2012 – conclusions and recommendations. , 2013, Releve epidemiologique hebdomadaire.
[42] J. Andrews. Determination of minimum inhibitory concentrations. , 2001, The Journal of antimicrobial chemotherapy.